Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Kavanagh

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Brachytherapy|January 31, 2016
Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data BaseArya Amini, Bernard L Jones, Matthew W Jackson, et al.
Medical Physics|August 17, 2012
High-dose MVCT image guidance for stereotactic body radiation therapyDavid C Westerly, Tracey E Schefter, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomasAmanda L Schwer, Denise M Damek, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Is Less, More? The Evolving Role of Radiation Therapy for Brain MetastasesScott G Soltys, John P Kirkpatrick, Nadia N Laack, et al.
The Journal of Urology|November 19, 2015
Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data BaseArya Amini, Bernard Jones, Matthew W Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation studyYevgeniy Vinogradskiy, Phillip J Koo, Richard Castillo, et al.
Journal of Neuro-Oncology|April 30, 2015
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trialsJulie A Carlson, Krishna Reddy, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastasesChristopher C Howells, Michelle A Stinauer, Quentin Diot, et al.
Urologic Oncology|March 18, 2014
The prognostic significance of Gleason scores in metastatic prostate cancerChad G Rusthoven, Julie A Carlson, Timothy V Waxweiler, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiformeKrishna Reddy, Denise Damek, Laurie E Gaspar, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Brachytherapy|January 31, 2016
Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data BaseArya Amini, Bernard L Jones, Matthew W Jackson, et al.
Medical Physics|August 17, 2012
High-dose MVCT image guidance for stereotactic body radiation therapyDavid C Westerly, Tracey E Schefter, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|October 31, 2007
A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomasAmanda L Schwer, Denise M Damek, Brian D Kavanagh, et al.
International Journal of Radiation Oncology, Biology, Physics|July 22, 2015
Is Less, More? The Evolving Role of Radiation Therapy for Brain MetastasesScott G Soltys, John P Kirkpatrick, Nadia N Laack, et al.
The Journal of Urology|November 19, 2015
Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data BaseArya Amini, Bernard Jones, Matthew W Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation studyYevgeniy Vinogradskiy, Phillip J Koo, Richard Castillo, et al.
Journal of Neuro-Oncology|April 30, 2015
Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trialsJulie A Carlson, Krishna Reddy, Laurie E Gaspar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2012
Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastasesChristopher C Howells, Michelle A Stinauer, Quentin Diot, et al.
Urologic Oncology|March 18, 2014
The prognostic significance of Gleason scores in metastatic prostate cancerChad G Rusthoven, Julie A Carlson, Timothy V Waxweiler, et al.
International Journal of Radiation Oncology, Biology, Physics|April 10, 2012
Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiformeKrishna Reddy, Denise Damek, Laurie E Gaspar, et al.
Pageof 15